Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

589 ARTÍCULOS , VIENDO DEL 391 AL 405

Perspectives and challenges in patient stratification in Alzheimer's disease

Abdelnour C, Agosta F, Bozzali M, Fougère B, Iwata A, Nilforooshan R, Takada LT, Viñuela F, Traber M.

Alzheimers Res Ther. 2022 Aug 13;14(1):112. doi: 10.1186/s13195-022-01055-y.

Recent updates in the development of small molecules as potential clinical candidates for Alzheimer's disease: A review

Umar T, Meena R, Mustehasan, Kumar P, Khan AA.

Chem Biol Drug Des. 2022 Nov;100(5):674-681. doi: 10.1111/cbdd.14133. Epub 2022 Sep 13.

Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias

Ding H, Reiss AB, Pinkhasov A, Kasselman LJ.

Medicina (Kaunas). 2022 Jul 30;58(8):1025. doi: 10.3390/medicina58081025.

Microbiota alteration and modulation in Alzheimer's disease by gerobiotics: The gut-health axis for a good mind

Ağagündüz D, Kocaadam-Bozkurt B, Bozkurt O, Sharma H, Esposito R, Özoğul F, Capasso R.

Biomed Pharmacother. 2022 Sep;153:113430. doi: 10.1016/j.biopha.2022.113430. Epub 2022 Jul 18.

Probiotics Treatment Can Improve Cognition in Patients with Mild Cognitive Impairment: A Systematic Review

Sánchez-de-Lara-Sánchez S, Sánchez-Pérez AM.

J Alzheimers Dis. 2022;89(4):1173-1191. doi: 10.3233/JAD-220615.

Functional Therapeutic Strategies Used in Different Stages of Alzheimer's Disease-A Systematic Review

Olczak A, Truszczyńska-Baszak A, Stępień A, Górecki K.

Int J Environ Res Public Health. 2022 Sep 18;19(18):11769. doi: 10.3390/ijerph191811769.

Clinical impact of amyloid PET using (18)F-florbetapir in patients with cognitive impairment and suspected Alzheimer's disease: a multicenter study

Matsuda H, Okita K, Motoi Y, Mizuno T, Ikeda M, Sanjo N, Murakami K, Kambe T, Takayama T, Yamada K, Suehiro T, Matsunaga K, Yokota T, Tateishi U, Shigemoto Y, Kimura Y, Chiba E, Kawashima T, Tomo Y, Tachimori H, Kimura Y, Sato N.

Ann Nucl Med. 2022 Dec;36(12):1039-1049. doi: 10.1007/s12149-022-01792-y. Epub 2022 Oct 4.

Effectiveness and safety of anti-tau drugs for Alzheimer's disease: Systematic review and meta-analysis

Zheng X, Tang Y, Yang Q, Wang S, Chen R, Tao C, Zhang P, Fan B, Zhan J, Tang C, Lu L.

J Am Geriatr Soc. 2022 Nov;70(11):3281-3292. doi: 10.1111/jgs.18025. Epub 2022 Oct 8.

Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment

Deng C, Chen H, Meng Z, Meng S.

Front Endocrinol (Lausanne). 2022 Sep 21;13:955618. doi: 10.3389/fendo.2022.955618. eCollection 2022.

Potential of food-derived bioactive peptides in alleviation and prevention of Alzheimer's disease

Zhao L, Li D, Qi X, Guan K, Chen H, Wang R, Ma Y.

Food Funct. 2022 Oct 31;13(21):10851-10869. doi: 10.1039/d2fo02278h.

Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia

Linh TTD, Hsieh YC, Huang LK, Hu CJ.

Int J Mol Sci. 2022 Sep 21;23(19):11067. doi: 10.3390/ijms231911067.

Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer's Disease

Tsai YT, Kao ST, Cheng CY.

Int J Mol Sci. 2022 Sep 25;23(19):11311. doi: 10.3390/ijms231911311.

Risks and benefits of current and novel drugs to treat agitation in Alzheimer's disease

Herrmann N, Wang HJ, Song BX, Bawa KK, Lanctôt KL.

Expert Opin Drug Saf. 2022 Oct;21(10):1289-1301. doi: 10.1080/14740338.2022.2136162. Epub 2022 Oct 20.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias